跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 767 条关于
“CD47-SIRPα”
全部
767
临床试验
411
药物
241
机构
1
资讯
114
9天前
FDA Clears HanchorBio's HCB101 Single-Patient Expanded Access Protocol, a First for SIRPα-Fc Fusion Proteins
2年前
Novel Agents Identified for Osteosarcoma Treatment in Children and Young Adults
去年
ImmuneOncia's CD47 Antibody IMC-002 Shows 30% Response Rate in Advanced Hepatocellular Carcinoma Trial
7个月前
Biosion Initiates Phase 1 Trial of BSI-082 Anti-SIRPα Antibody for Advanced Solid Tumors
2年前
CD47-Targeted Immunotherapies Show Promise in Cancer Treatment
去年
Evorpacept Plus Zanidatamab Shows Promise in HER2-Positive and HER2-Low Metastatic Breast Cancer
去年
Akeso's Phase 3 Trial Begins for Ivonescimab and Ligufalimab Combination in Head and Neck Cancer
去年
ImmuneOnco's CD47xCD20 Bispecific IMM0306 Advances to Phase II with Promising Efficacy in B-Cell Lymphomas
去年
Akeso Initiates Phase 3 Trial of Ivonescimab Plus Ligufalimab in Head and Neck Cancer
2个月前
Tumor Microenvironment Modulation Market Projected to Reach USD 3.73 Billion by 2031, Growing at 7.4% CAGR
第 1 页,共 12 页
上一页
下一页